Notably, recent studies have shown that myeloid-specific Arg1 knockout alone is not sufficient to prevent cancer-induced wasting in mice, suggesting that additional factors are likely required to drive the full progression of muscle wasting [12]. This evidence concerns the gene ARG1 and cancer.